伴11q异常的侵袭性B细胞淋巴瘤谱系超出伯基特样淋巴瘤
研究扩展了侵袭性B细胞淋巴瘤队列(含47例双重/三重打击淋巴瘤),用FISH检测11q缺失或11q近端增益/缺失模式。首次发现11q异常可见于HIV相关伯基特样淋巴瘤及伴MYC、BCL2和/或BCL6重排的高级别B细胞淋巴瘤,提示该异常相关肿瘤谱系可能更广。
要点
- 11q异常不仅见于BLL-11q,也见于HIV相关BLL和双/三重打击淋巴瘤。
- 对组织学介于DLBCL和BL之间的病例应关注11q异常检测。
- 伴11q异常的侵袭性B细胞淋巴瘤临床病理谱系可能更宽。
核心结论
- 伴11q异常的侵袭性B细胞淋巴瘤临床病理谱系可能比既往认为的更广。
研究设计与样本
- 扩展的侵袭性B细胞淋巴瘤队列,富集组织学介于DLBCL和BL之间的病例,含47例双重/三重打击淋巴瘤,用FISH检测11q缺失或11q近端增益/缺失模式。
主要发现
- 在HIV+高级别B细胞淋巴瘤患者中发现端粒11q缺失。
- 11q异常可见于HIV相关伯基特样淋巴瘤。
- 11q异常可见于伴MYC、BCL2和/或BCL6重排的高级别B细胞淋巴瘤。
临床怎么用
- 对组织学介于DLBCL和BL之间的侵袭性B细胞淋巴瘤,可考虑FISH检测11q异常。
- HIV相关伯基特样淋巴瘤及双/三重打击淋巴瘤中应留意11q异常。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The recent characterization of a group of non-MYC rearranged aggressive B-cell lymphomas, resembling Burkitt lymphoma (BL), characteristically harboring a telomeric 11q loss or combined 11q proximal gains/loss pattern has led to the introduction of the provisional entity of Burkitt-like lymphoma with 11q aberration (BLL-11q). Prompted by the discovery of a telomeric 11q loss in an HIV+ high-grade B-cell lymphoma patient, we investigated an extended cohort of aggressive B-cell lymphomas, enriched for cases with histopathological features intermediate between DLBCL and BL, including double- and triple-hit lymphomas (n = 47), for 11q loss/combined 11q proximal gains/loss pattern by fluorescence in situ hybridization. We provide first evidence that 11q aberrations can be found in both BLL in the context of an underlying HIV infection as well as in high-grade B-cell lymphomas with MYC, BCL2, and/or BCL6 rearrangements. We therefore propose that the clinicopathological spectrum of malignancies carrying this aberration may be broader than previously assumed.
引用
- Gebauer N, Witte HM, Merz H, et al. Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma. Blood Adv. 2021. PMID: 34500469. doi:10.1182/bloodadvances.2021004635
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。